Tech Company Inital Public Offerings
Omeros IPO
Omeros was acquired by . Shares became public on 10/8/2009.
Transaction Overview
Company Name
Announced On
10/8/2009
Transaction Type
IPO
Amount
$68,200,000
Proceeds Purpose
Proceeds purposes from the IPO are on file with the company statements at the SEC.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
201 Elliott Ave. West The Omeros Building
Seattle, WA 98119
USA
Seattle, WA 98119
USA
Phone
Website
Email Address
Overview
Omeros recognized that a combination of agents acting on multiple molecular targets may be required for optimal therapeutic effect. Omeros' product candidates are designed to modulate the molecular mechanisms of pathologic conditions rather than just treating their symptoms.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gregory Demopulos
Chief Medical Officer
Steven Whitaker
Chief Scientific Officer
George Gaitanaris
VP - Bus. Development
Timothy Duffy
VP - Finance
Michael Jacobsen
VP - Regulatory Affairs
Catherine Melfi
Browse more venture capital transactions:
Prev: 10/8/2009: Surf Canyon venture capital transaction
Next: 10/8/2009: Solvate venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs